Trikafta

Active Ingredient(s): Elexacaftor + Ivacaftor + Tezacaftor
FDA Approved: * October 21, 2019
Pharm Company: * VERTEX PHARMS INC
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Trikafta Overview

Elexacaftor/ivacaftor/tezacaftor, sold under the brand name Trikafta, is a combination medication used in those that have cystic fibrosis with a f508del mutation.[1] It is made up of a combination of elexacaftor, ivacaftor, and tezacaftor.[1] It was approved for medical use in the United States in 2019.[1][2][3] The list price in the US is expected to be $311,000 per year.[4] Contents 1 Pharmac...

Read more Trikafta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Elexacaftor/ivacaftor/tezacaftor

Recent Trikafta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Elexacaftor + Ivacaftor + Tezacaftor
  • Tablet, Tablet: 100mg,75mg,50mg + N/a,150mg,n/a
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (7 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 26 January 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA